Maternal and Infant Growth Study

NCT ID: NCT02893319

Last Updated: 2018-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

115 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rapid growth early in infancy is a risk factor for obesity and cardiovascular disease later in the lifespan. Evidence is limited, but both pre- and postnatal factors are associated with early rapid growth, and include high maternal BMI prior to pregnancy and excessive gestational weight gain. This research focuses on aspects of early feeding as potentially modifiable factor affecting early infant weight gain. Formula feeding mothers are randomized to receive either 5 oz of 8 oz bottles to use in feeding their infants from 2- to 16 weeks postpartum. In addition, a reference group of exclusively breastfeeding mother-infant dyads are also included. The hypothesis is that differences in feeding practices will be associated with differences in growth and that infants randomized to be fed from smaller bottles will grow more slowly that those randomized to larger bottles. Growth patterns of formula fed infants will also be compared to those of exclusively breastfed infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mothers complete feeding logs, questionnaires on health history, demographics, feeding attitudes and practices. Infant growth and body composition are measured via PEA POD, and maternal anthropometrics and body composition are measured in BOD POD the laboratory at 2, 8, and 16 weeks postpartum. Primary outcome is change in weight-for-age z-scores.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternal Behavior Body Weight Infant Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breastfeeding

control group

Group Type NO_INTERVENTION

No interventions assigned to this group

5 oz bottle

Subject will feed infant with 5oz medela bottle

Group Type ACTIVE_COMPARATOR

Feeding and growth differences, 5oz vs 8oz bottle

Intervention Type BEHAVIORAL

Group A: 5oz bottle Group B: 8oz bottle

8 oz bottle

Subject will feed infant with 8oz medela bottle

Group Type ACTIVE_COMPARATOR

Feeding and growth differences, 5oz vs 8oz bottle

Intervention Type BEHAVIORAL

Group A: 5oz bottle Group B: 8oz bottle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Feeding and growth differences, 5oz vs 8oz bottle

Group A: 5oz bottle Group B: 8oz bottle

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant or newborn aged 28 days or younger

Exclusion Criteria

* gestational diabetes, hypertension, pregnancy/delivery complications, premature birth, low birth weight
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Leann Birch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Leann Birch

William P. Flatt Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leann L Birch, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Georgia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013102510

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevention of Overweight in Infancy
NCT00892983 COMPLETED NA
Prevention of Childhood Obesity
NCT00788203 COMPLETED
LIMIT Early Adiposity Rebound in Children
NCT04960670 NOT_YET_RECRUITING
Assessing Better Bottles for Babies
NCT06357299 RECRUITING NA